Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009. https://doi.org/10.1038/nrdp.2017.9.
Article PubMed PubMed Central Google Scholar
Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79–87. https://doi.org/10.14740/wjon1279.
Article PubMed PubMed Central Google Scholar
Ciccarese C, Strusi A, Arduini D, Russo P, Palermo G, Foschi N, et al. Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario. Cancer Treat Rev. 2023;115:102528. https://doi.org/10.1016/j.ctrv.2023.102528.
Article CAS PubMed Google Scholar
Dabestani S, Thorstenson A, Lindblad P, Harmenberg U, Ljungberg B, Lundstam S. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol. 2016;34(8):1081–6. https://doi.org/10.1007/s00345-016-1773-y.
Abou Elkassem AM, Lo SS, Gunn AJ, Shuch BM, Dewitt-Foy ME, Abouassaly R, et al. Role of imaging in renal cell carcinoma: a multidisciplinary perspective. Radiographics. 2021;41(5):1387–407. https://doi.org/10.1148/rg.2021200202.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75(5):799–810. https://doi.org/10.1016/j.eururo.2019.02.011.
Liu BX, Sun W, Kong XQ. Perirenal fat: a unique fat pad and potential target for cardiovascular disease. Angiology. 2019;70(7):584–93. https://doi.org/10.1177/0003319718799967.
Rajandram R, Perumal K, Yap NY. Prognostic biomarkers in renal cell carcinoma: is there a relationship with obesity? Transl Androl Urol. 2019;8(Suppl 2):S138–46. https://doi.org/10.21037/tau.2018.11.10.
Article PubMed PubMed Central Google Scholar
Tsai JP, Lin DC, Huang WM, Chen M, Chen YH. Comparison of perinephric fat measurements between malignant and benign renal tumours. J Int Med Res. 2022;50(9):3000605221125086. https://doi.org/10.1177/03000605221125086.
Article CAS PubMed Google Scholar
Du Y, Yang W, Liu H, Qin C, Tang X, Xu T. Perirenal fat as a new independent prognostic factor in patients with surgically treated clear cell renal cell carcinoma. Clin Genitourin Cancer. 2022;20(1):e75–80. https://doi.org/10.1016/j.clgc.2021.10.006.
Huang H, Chen S, Li W, Wu X, Xing J. High perirenal fat thickness predicts a poor progression-free survival in patients with localized clear cell renal cell carcinoma. Urol Oncol. 2018;36(4):157.e1-157.e6. https://doi.org/10.1016/j.urolonc.2017.12.011.
Rosenquist KJ, Pedley A, Massaro JM, Therkelsen KE, Murabito JM, Hoffmann U, et al. Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imaging. 2013;6(7):762–71. https://doi.org/10.1016/j.jcmg.2012.11.021.
Article PubMed PubMed Central Google Scholar
Wang H, Wei Y, Hu X, Pan J, Wu J, Wang B, et al. Fat attenuation ındex of renal cell carcinoma reveals biological characteristics and survival outcome. Front Oncol. 2022;12:786981. https://doi.org/10.3389/fonc.2022.786981.
Article CAS PubMed PubMed Central Google Scholar
Sun Z, Zhang Y, Xia Y, Ba X, Zheng Q, Liu J, et al. Association between CT-based adipose variables, preoperative blood biochemical indicators and pathological T stage of clear cell renal cell carcinoma. Heliyon. 2024;10(2):e24456. https://doi.org/10.1016/j.heliyon.2024.e24456.
Article CAS PubMed PubMed Central Google Scholar
Elkassem AA, Allen BC, Sharbidre KG, Rais-Bahrami S, Smith AD. Update on the role of imaging in clinical staging and restaging of renal cell carcinoma based on the AJCC 8th edition from the AJR special series on cancer staging. AJR Am J Roentgenol. 2021;217(3):541–55. https://doi.org/10.2214/AJR.21.25493.
Liu H, Kong QF, Li J, Wu YQ, Pan KH, Xu B, et al. A meta-analysis for comparison of partial nephrectomy vs. radical nephrectomy in patients with pT3a renal cell carcinoma. Transl Androl Urol. 2021;10(3):1170–8. https://doi.org/10.21037/tau-20-1262.
Article PubMed PubMed Central Google Scholar
Hori S, Tanaka N, Iida K, Nakai Y, Miyake M, Anai S, et al. Impact of radical nephrectomy and partial nephrectomy on actual estimated overall survival compared to life expectancy in patients with renal cell carcinoma. Res Rep Urol. 2021;13:155–65. https://doi.org/10.2147/RRU.S299801.
Article PubMed PubMed Central Google Scholar
Hu H, Liang W, Zhang Z, Liu Z, Chu F, Bao Y, et al. The Utility of perirenal fat in determining the risk of onset and progression of diabetic kidney disease. Int J Endocrinol. 2022;2022:2550744. https://doi.org/10.1155/2022/2550744.
Article CAS PubMed PubMed Central Google Scholar
Klatte T, Rossi SH, Stewart GD. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J Urol. 2018;36(12):1943–52. https://doi.org/10.1007/s00345-018-2309-4.
Rakic I, Rakic N, Stephens A, Corsi N, Davis M, Tinsley S, et al. Assessing the impact of lymphovascular invasion on overall survival in surgically treated renal cell carcinoma patients: a nationwide cohort analysis. Urol Oncol. 2023;41(10):435.e1-435.e9. https://doi.org/10.1016/j.urolonc.2023.07.011.
Suárez C, Campayo M, Bastús R, Castillo S, Etxanitz O, Guix M, et al. Prognostic and predictive factors for renal cell carcinoma. Target Oncol. 2018;13(3):309–31. https://doi.org/10.1007/s11523-018-0557-2.
Bruna FA, Romeo LR, Campo-Verde-Arbocco F, Contador D, Gómez S, Santiano F, et al. Human renal adipose tissue from normal and tumor kidney: its influence on renal cell carcinoma. Oncotarget. 2019;10(52):5454–67. https://doi.org/10.18632/oncotarget.27157.
Article PubMed PubMed Central Google Scholar
Campo-Verde-Arbocco F, López-Laur JD, Romeo LR, Giorlando N, Bruna FA, Contador DE, et al. Human renal adipose tissue induces the invasion and progression of renal cell carcinoma. Oncotarget. 2017;8(55):94223–34. https://doi.org/10.18632/oncotarget.21666.
Article PubMed PubMed Central Google Scholar
Zhang Y, Coletta AM, Allen PK, Parikh AM, Cox-Mattin M, Meyer LA, et al. Perirenal adiposity is associated with lower progression-free survival from ovarian cancer. Int J Gynecol Cancer. 2018;28(2):285–92. https://doi.org/10.1097/IGC.0000000000001165.
Article PubMed PubMed Central Google Scholar
Kuo YR, Lee YC, Wang CT, Liu WC, Ou CH, Lin KC, et al. Prognostic value of preoperative radiographic perinephric fat features in renal cell carcinoma patients undergoing surgery. Asian J Surg. 2024;47:2188–94. https://doi.org/10.1016/j.asjsur.2024.02.048.
Ferrando M, Bruna FA, Romeo LR, Contador D, Moya-Morales DL, Santiano F, et al. Renal peritumoral adipose tissue undergoes a browning process and stimulates the expression of epithelial-mesenchymal transition markers in human renal cells. Sci Rep. 2022;12(1):8687. https://doi.org/10.1038/s41598-022-12746-9.
Article CAS PubMed PubMed Central Google Scholar
Ahmadi N, Hajsadeghi F, Conneely M, Mingos M, Arora R, Budoff M, et al. Accurate detection of metabolically active “brown” and “white” adipose tissues with computed tomography. Acad Radiol. 2013;20(11):1443–7. https://doi.org/10.1016/j.acra.2013.08.012.
Preza-Fernandes J, Passos P, Mendes-Ferreira M, Rodrigues AR, Gouveia A, Fraga A, et al. A hint for the obesity paradox and the link between obesity, perirenal adipose tissue and renal cell carcinoma progression. Sci Rep. 2022;12(1):19956. https://doi.org/10.1038/s41598-022-24418-9.
Comments (0)